Help
RSS
API
Feed
Maltego
Contact
Domain > ir.fibrobiologics.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2025-09-16
35.171.180.101
(
ClassC
)
2026-02-26
52.52.175.53
(
ClassC
)
Port 443
HTTP/1.1 200 OKDate: Thu, 26 Feb 2026 02:15:58 GMTServer: ApacheX-Frame-Options: SAMEORIGINStrict-Transport-Security: max-age31536000;X-XSS-Protection: 1; modeblockX-Content-Type-Options: nosniffFeature-Policy: microphone none; camera none; geolocation none; screen-wake-lock none;Referrer-Policy: strict-origin-when-cross-originContent-Security-Policy: default-src *.gstatic.com ir.stockpr.com ir.fibrobiologics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; script-src *.quotemedia.com *.google.com *.google-analytics.com *.gstatic.com *.hcaptcha.com hcaptcha.com dev-ir.stockpr.com www.youtube.com player.vimeo.com *.found.io *.googletagmanager.com *.doubleclick.net cdn-cookieyes.com log.cookieyes.com directory.cookieyes.com connect.facebook.net www.facebook.com ir.stockpr.com ir.fibrobiologics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline; connect-src *.quotemedia.com *.google.com *.google-analytics.com *.gstatic.com *.hcaptcha.com hcaptcha.com dev-ir.stockpr.com www.youtube.com player.vimeo.com *.found.io *.googletagmanager.com *.doubleclick.net cdn-cookieyes.com log.cookieyes.com directory.cookieyes.com connect.facebook.net www.facebook.com ir.stockpr.com ir.fibrobiologics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline; style-src fonts.googleapis.com *.gstatic.com *.hcaptcha.com hcaptcha.com dev-ir.stockpr.com qmod.quotemedia.com static.c1.quotemedia.com ir.stockpr.com ir.fibrobiologics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net unsafe-inline; font-src cdnjs.cloudflare.com/ajax/libs/font-awesome/ fonts.googleapis.com *.gstatic.com static.c1.quotemedia.com ir.stockpr.com ir.fibrobiologics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; img-src i.ytimg.com qmod.quotemedia.com *.prnewswire.com c212.net match.adsrvr.org uipglob.semasio.net *.doubleclick.net *.google.com ml.globenewswire.com cdn-cookieyes.com www.facebook.com ir.stockpr.com ir.fibrobiologics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; frame-src *.google.com youtube.com www.youtube.com youtube-nocookie.com www.youtube-nocookie.com vimeo.com player.vimeo.com *.hcaptcha.com hcaptcha.com *.doubleclick.net www.googletagmanager.com ir.stockpr.com ir.fibrobiologics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net; object-src *.gstatic.com ir.stockpr.com ir.fibrobiologics.com d1io3yog0oux5.cloudfront.net *.equisolve-dev.com *.equisolve.net;Vary: Accept-EncodingTransfer-Encoding: chunkedContent-Type: text/html; charsetUTF-8 !DOCTYPE html>html langen> head> !-- Start cookieyes banner --> script idcookieyes typetext/javascript srchttps://cdn-cookieyes.com/client_data/1d4c6b8f70ae78e51c1abc14b261a4e2/script.js>/script> !-- End cookieyes banner --> meta http-equivx-ua-compatible contentieedge> meta charsetutf-8> link relalternate typeapplication/rss+xml titleFibroBiologics, Inc. - Recent News hrefhttps://ir.fibrobiologics.com/news-events/press-releases/rss /> title>FibroBiologics, Inc. (FBLG)/title> link relcanonical hrefhttps://ir.fibrobiologics.com>meta propertyog:url contenthttps://ir.fibrobiologics.com>meta propertyog:site_name contentFibroBiologics, Inc.>meta propertyog:title contentInvestors>meta propertyog:type contentwebsite>meta propertyog:image contenthttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/db/2287/20607/social_image_resized.jpg>meta nametwitter:card contentsummary_large_image>meta propertyog:description contentFibroBiologics is a cell therapy, regenerative medicine company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 150+ US and…>meta namedescription contentFibroBiologics is a cell therapy, regenerative medicine company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 150+ US and…>script typeapplication/ld+json> {@context:http:\/\/schema.org,@type:Corporation,name:FibroBiologics, Inc.,address:{@type:PostalAddress,streetAddress:455 E. Medical Center Blvd. Suite 300,addressLocality:Houston, TX,postalCode:77598,addressCountry:},legalName:FibroBiologics, Inc.,description:FibroBiologics is a cell therapy, regenerative medicine company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 150+ US and internationally issued patents\/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.,tickerSymbol:: FBLG,url:https:\/\/ir.fibrobiologics.com,logo:https:\/\/d1io3yog0oux5.cloudfront.net\/_c6c579a40f7c28ecf7724fd2a536e0eb\/fibrobiologics\/logo.png,image:https:\/\/d1io3yog0oux5.cloudfront.net\/_c6c579a40f7c28ecf7724fd2a536e0eb\/fibrobiologics\/db\/2287\/20607\/social_image_resized.jpg,sameAs:}/script>!-- Elastic Search --> meta nameviewport contentinitial-scale1.0, widthdevice-width> link relpreconnect hrefhttps://d1io3yog0oux5.cloudfront.net> link relpreconnect hrefhttps://qmod.quotemedia.com> link hrefhttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/files/theme/css/ir.stockpr.css relstylesheet typetext/css mediascreen /> link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/files/theme/css/child_style_arc.css> link relstylesheet hrefhttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/files/theme/css/style.css> link relshortcut icon hrefhttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/files/theme/images/favicons/favicon.ico> link relapple-touch-icon sizes180x180 hrefhttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/files/theme/images/favicons/apple-touch-icon.png> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/files/theme/images/favicons/favicon-32x32.png sizes32x32> link relicon typeimage/png hrefhttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/files/theme/images/favicons/favicon-16x16.png sizes16x16> link relmanifest hrefhttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/files/theme/images/favicons/manifest.json> link relmask-icon hrefhttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/files/theme/images/favicons/safari-pinned-tab.svg> meta nametheme-color content#ffffff> !-- Google GA4 code (gtag.js) -->script srchttps://www.googletagmanager.com/gtag/js?idG-YYVNBX0H6K async>/script>script> window.dataLayer window.dataLayer || ; function gtag(){dataLayer.push(arguments);} gtag(js, new Date()); gtag(config, G-YYVNBX0H6K); /script>!-- END Google GA4 code (gtag.js) --> !-- Meta Pixel Code -->script> !function(f,b,e,v,n,t,s) {if(f.fbq)return;nf.fbqfunction(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}; if(!f._fbq)f._fbqn;n.pushn;n.loaded!0;n.version2.0; n.queue;tb.createElement(e);t.async!0; t.srcv;sb.getElementsByTagName(e)0; s.parentNode.insertBefore(t,s)}(window,document,script, https://connect.facebook.net/en_US/fbevents.js); fbq(init, 2309498322886375); fbq(track, PageView);/script>noscript> img height1 width1 srchttps://www.facebook.com/tr?id2309498322886375&evPageView&noscript1/>/noscript>!-- End Meta Pixel Code --> /head>body class107607 page-type-ir-overview ir-template-arc ir > div classgeneral-wrapper> nav idheader classaffixed aria-labelMain> div idskipLinks> a href#mainContent>Skip to main content/a> a href#footer>Skip to footer/a> /div> div classzero-nav d-none d-lg-block> div classcontainer> div classrow justify-content-between align-items-center> div classcol-2> div classd-flex justify-content-start zero-nav-home-link> a href/>Investor Relations/a> /div> /div> div classcol-10> div classzero-nav-links> a hrefhttps://fibrobiologics.com/ target_blank relnoopener>Back to fibrobiologics.com/a> /div> /div> /div> /div>/div> div classcontainer> div classd-flex justify-content-between> div classlogo> a href/> img srchttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/db/2323/21401/image.svg width200 height50 altFibroBiologics, Inc.> /a> /div> a rolebutton classmobile-nav-trigger idshowRight aria-labelExpand main navigation aria-controlsmobile-nav> div classmeat>/div> div classmeat>/div> div classmeat>/div> /a> div classcbp-spmenu cbp-spmenu-vertical cbp-spmenu-right main-nav idmobile-nav> ul classmain-menu> li classactive active-landing data-submenu-idsubmenu-overview> a href/ target_self >Overview/a> /li> li classhas-children data-submenu-idsubmenu-news-events> a href/news-events target_self >News & Events/a> ul idsubmenu-news-events> li class> a href/news-events/press-releases target_self >Press Releases/a> /li> li class> a href/news-events/ir-calendar target_self >IR Calendar/a> /li> li class> a href/news-events/presentations target_self >Presentations/a> /li> li class> a href/news-events/email-alerts target_self >Email Alerts/a> /li> /ul> /li> li classhas-children data-submenu-idsubmenu-company-information> a hrefhttps://fibrobiologics.com/about-us/ target_blank relnoopener>Company Info/a> ul idsubmenu-company-information> li class> a hrefhttps://fibrobiologics.com/about-us/ target_blank relnoopener>Company Profile/a> /li> li class> a hrefhttps://fibrobiologics.com/about-us/#leadership target_blank relnoopener>Executive Team/a> /li> li class> a href/company-information/contacts target_self >Contacts/a> /li> li class> a href/company-information/faq target_self >FAQ/a> /li> /ul> /li> li classhas-children data-submenu-idsubmenu-financial-information> a href/financial-information target_self >Financial Info/a> ul idsubmenu-financial-information> li class> a href/financial-information/financial-results target_self >Financial Results/a> /li> /ul> /li> li classhas-children data-submenu-idsubmenu-stock-data> a href/stock-data target_self >Stock Data/a> ul idsubmenu-stock-data> li class> a href/stock-data/quote-chart target_self >Quote and Chart/a> /li> li class> a href/stock-data/historical-data target_self >Historical Data/a> /li> li class> a href/stock-data/analyst-coverage target_self >Analyst Coverage/a> /li> /ul> /li> li classhas-children data-submenu-idsubmenu-sec-filings> a href/sec-filings target_self >SEC Filings/a> ul idsubmenu-sec-filings> li class> a href/sec-filings/all-sec-filings target_self >All SEC Filings/a> /li> li class> a href/sec-filings/annual-reports target_self >Annual Reports/a> /li> li class> a href/sec-filings/quarterly-reports target_self >Quarterly Reports/a> /li> li class> a href/sec-filings/section-16-filings target_self >Section 16 Filings/a> /li> /ul> /li> li classhas-children last-item data-submenu-idsubmenu-corporate-governance> a href/corporate-governance target_self >Governance/a> ul idsubmenu-corporate-governance> li class> a href/corporate-governance target_self >Overview/a> /li> li class> a hrefhttps://fibrobiologics.com/about-us/#leadership target_blank relnoopener>Board of Directors/a> /li> li class> a href/corporate-governance/board-committees target_self >Board Committees/a> /li> li class> a href/corporate-governance/governance-documents target_self >Governance Documents/a> /li> /ul> /li> li classd-block d-lg-none> a hrefhttps://fibrobiologics.com/ target_blank relnoopener> Back to fibrobiologics.com /a>/li>/ul> /div> /div> /div>/nav> div classeq-container> header classpage-banner overlay stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/files/theme/images/child_themes/ir-cta-default_arc.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;background-color: #333;> div classcontainer> div classrow> div classcol-lg-12> div classtext> h1>Investor Relations /h1> /div> /div> /div> /div>/header> main idmainContent> div classmodule row-media-news-event-image > div classcontainer> div classrow> div classcol-lg> div classcontent-box> div classtext> div classcontent> div classnews-heading> h2 classheading--h3>Latest News/h2> a hrefhttps://ir.fibrobiologics.com/news-events/press-releases classbtn>View All News/a> /div> article classmedia> div classrow> div classmedia-body col-md> div classdate> time datetime2026-02-24T16:30:00>Feb 24, 2026 • 4:30 PM EST/time> /div> h3 classmedia-heading>FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update/h3> a hrefhttps://ir.fibrobiologics.com/news-events/press-releases/detail/102/fibrobiologicsreportsfull-year-2025-financial-resultsand-provides-corporate-update classblock-link>Read Press Release/a> /div> /div>/article>article classmedia> div classrow> div classmedia-body col-md> div classdate> time datetime2026-02-23T08:30:00>Feb 23, 2026 • 8:30 AM EST/time> /div> h3 classmedia-heading>FibroBiologics Granted Extension by Nasdaq to Regain Compliance/h3> a hrefhttps://ir.fibrobiologics.com/news-events/press-releases/detail/101/fibrobiologics-granted-extension-by-nasdaq-to-regain-compliance classblock-link>Read Press Release/a> /div> /div>/article> /div> /div> /div> /div> div classcol-lg> div classcontent-box> div classimage-wrapper> img srchttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/db/2375/21410/image.png altemployees discussing with whiteboard /> /div> div classtext> div classcontent> div classevent-item> time datetime2026-06-29T00:00:00 classdate> Jun 29 – Jul 1, 2026 /time> h2>Upcoming Event/h2> h3 classcontent-box-title> A4LI’s H-SPAN Summit at Georgetown University /h3> div classinline-block-links> a href/ical?id21496 classblock-link>Add to Calendar/a> a href/news-events/ir-calendar classblock-link>View All Events/a> /div> /div> /div> /div> /div> /div>!-- /item--> /div> /div>/div>section classmodule row-default ir-company-overview row-ir-company-overview-stock background overlay dark stylebackground: url(https://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/db/2375/21412/background_image.jpg);background-position: 50% 50%;background-repeat: no-repeat;background-size: cover;background-color: #333;> div classcontainer> div classrow> div classcol-lg-6> div classmodule-content> div classtext-area> div classtext> h2>Company Information/h2> p>FibroBiologics is a cell therapy, regenerative medicine company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 150+ US and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy./p> /div> /div> /div> a target_blank href/company-information/executive-team classbtn mb-3>View Executive Team/a>br> a target_blank href/company-information/executive-team classbtn>View Board of Directors/a> /div> div classcol-lg-6> div classstock-info-section> div classcontent> div classstock-info quote-box qtool data-qmod-tooldetailedquotetab data-qmod-params{"lang":"en","showLogo":false,"lowHigh":false,"symbol":"FBLG"}> span classloader>/span> script typetext/template> div classqmod-ui-tool> h2 classsr-only>Stock information/h2> div classrow stock-summary> div classcol-7> p classvalue-market-symbol heading--h3>Nasdaq: FBLG /p> /div> div classcol-5> p classheading--h3 value positive-value>${data.pricedata.last | asQHLast tLang }/p> /div> /div> div classrow stock-stats> div classcol-sm-6 col-12 change stock-section> div classstock-box change same-height> h3 classvalue-title>Change/h3> span> span classvalue> span rv-qmodchangedata.pricedata.change classqmod-change> span classnumber>{data.pricedata.change | asQHLast tLang }/span> span classpercent> ({data.pricedata.changepercent | numeraljs 0.00 0.00 | postFix %})/span> /span> /span> /span> /div> /div> div classcol-sm-6 col-12 stock-section> div classstock-box volume same-height> h3 classvalue-title>Volume/h3> span classvalue>{data.pricedata.sharevolume | numeraljs 0.00a}/span> /div> /div> div classcol-sm-6 col-12 stock-section> div classstock-box day-range same-height> h3 classvalue-title>Day Range/h3> p classvalue>${data.pricedata.low | asQHLast tLang} - ${data.pricedata.high | asQHLast tLang}/p> /div> !-- .stock-box --> /div> !-- .stock-section --> div classcol-sm-6 col-12 stock-section> div classstock-box week-range same-height> h3 classvalue-title>52 Week Range/h3> p classvalue>${data.fundamental.week52low.content | asQHLast tLang} - ${data.fundamental.week52high.content | asQHLast tLang}/p> /div> !-- .stock-box --> /div> !-- .stock-section --> div classstock-info-link> a href/stock-data/quote-chart classblock-link>View Detailed Stock Information/a> /div> /div> div classrow stock-disclaimer> div classcol-sm-6 col-12 date> p>{data.pricedata.lasttradedatetime | momentjs true LLL tLang} {data.tz | asTimezone tLang}/p> /div> div classcol-sm-6 col-12 notice> p>Pricing delayed by 20 minutes/p> /div> /div> /div>/script> /div>!--end stock-info--> /div> /div> /div> /div> /div>/section>div idfinancial-results classmodule module-overview-financial-results > div classcontainer> div classrow> div classcol-lg-12> div classresults text> div classmodule-header text> h2>Latest Financial Results/h2> /div> div classtext> div class row> div classcol-md-4 results-info> h3>FY 2025/h3> div classdate>Fiscal Year Ended Dec 31, 2025/div> /div> div classcol-md-8> div classresult-line> div classrow justify-space-between> div classcol-auto file-title> a hrefhttps://ir.fibrobiologics.com/news-events/press-releases/detail/102/fibrobiologicsreportsfull-year-2025-financial-resultsand-provides-corporate-update/>Earnings Release/a> /div> div classcol file-links> a hrefhttps://ir.fibrobiologics.com/news-events/press-releases/detail/102/fibrobiologicsreportsfull-year-2025-financial-resultsand-provides-corporate-update titleFibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update classlink>span classeqicon-HTML>/span>HTML/a> a hrefhttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/news/2026-02-24_FibroBiologics_Reports_Full_Year_2025_Financial_102.pdf classlink aria-labelPDF: FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update target_blank relnoopener>span classeqicon-PDF>/span>PDF/a> /div> /div> /div>div classresult-line> div classrow justify-space-between> div classcol-auto file-title> a href/sec-filings/all-sec-filings/content/0001193125-26-066965/fblg-20251231.htm aria-labelView HTML of 10-K target_blank relnoopener>10-K/a> /div> div classcol file-links> a href/sec-filings/all-sec-filings/content/0001193125-26-066965/fblg-20251231.htm aria-labelView HTML of 10-K target_blank relnoopener classlink>span classeqicon-HTML>/span>HTML/a> a href/sec-filings/all-sec-filings/content/0001193125-26-066965/0001193125-26-066965.pdf aria-labelView PDF of 10-K classlink target_blank relnoopener>span classeqicon-PDF>/span>PDF/a> /div> /div>/div>div classresult-line> div classrow justify-content-between> div classcol-auto file-title> a href/sec-filings/all-sec-filings/content/0001193125-26-066965/0001193125-26-066965-xbrl.zip titleDownload Raw XBRL Files target_blank relnoopener>XBRL/a> /div> div classcol file-links> a href/sec-filings/all-sec-filings/content/0001193125-26-066965/0001193125-26-066965-xbrl.zip titleDownload Raw XBRL Files classlink target_blank relnoopener>span classeqicon-ZIP>/span>ZIP/a> /div> /div>/div> /div> /div>/div> /div> /div> /div> div classar-row row align-items-center> div classcol-lg-8 p-0> section> div classcontent-wrapper> h2>Latest Annual Filing/h2> p>For Fiscal Year Ending Dec 31, 2025/p> /div> /section> /div> div classcol-lg-4 p-0> section classreport-links> h3 classsr-only>Report Links/h3> nav classinline-btns right aria-labelledbydocument-navigation> h4 iddocument-navigation classsr-only>Annual Report Document Links/h4> a href/sec-filings/all-sec-filings/content/0001193125-26-066965/0001193125-26-066965.pdf classbtn target_blank relnoopener>View 10-K/a> /nav> /section> /div> /div> /div>/div>section classmodule contact-info row-email-alerts-ir-contacts-alt no-padding-top no-padding-bottom > div classcontainer-fluid> div classtext> div classrow primary-row> div classcol-lg-6 col-12 email-info dark primary-color-bg> h2>Email Alerts/h2> p>Sign up today and receive company updates straight to your inbox./p> a classbtn href/news-events/email-alerts>Sign Up Today/a> /div> div classcol-lg-6 col-12 contacts> h2>IR Contacts/h2> div classrow> div classcol-lg contact-col data-mhcontact-col> h3 data-mhcontact-col-title>Company/h3> p> FibroBiologics, Inc.br> 455 E. Medical Center Blvd.br> Suite 300br> Houston, TX 77598 br> T: 281-671-5150 br>a hrefmailto:info@fibrobiologics.com>info@fibrobiologics.com/a> /p> /div> div classcol-lg contact-col data-mhcontact-col> h3 data-mhcontact-col-title>Investor Relations/h3> p> Russo Partnersbr> Nic Johnsonbr> T: 212-845-4242br> a hrefmailto:fibrobiologicsIR@russopr.com>fibrobiologicsIR@russopr.com/a>br> /p> /div> div classcol-lg contact-col data-mhcontact-col> h3 data-mhcontact-col-title>Transfer Agent/h3> p> VStock Transfer LLCbr> 18 Lafayette Placebr> Woodmere, NY 11598br> T: 212-828-8436br> /p> /div> /div> /div> /div> /div> /div>/section>section classmodule module-social-connect row-social-connect-alt > div classcontainer> div classrow> div classcol-lg-6 col-md-12> div classtext> h2>Connect With Us/h2> /div> /div> div classcol-lg-6 col-md-12> div classsocial-icons> div classrow> div classicon> a hrefhttps://www.facebook.com/ target_blank relnoopener> img srchttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/db/2289/21295/icon/icon-facebook.svg altVisit us on Facebook /> span>Facebook/span> /a> /div> div classicon> a hrefhttps://twitter.com/ target_blank relnoopener> img srchttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/db/2289/21296/icon/icon-twitter.svg altVisit us on Twitter /> span>Twitter/span> /a> /div> div classicon> a hrefhttps://www.linkedin.com/ target_blank relnoopener> img srchttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/db/2289/21297/icon/icon-linkedin.svg altVisit us on Linkedin /> span>Linkedin/span> /a> /div> div classicon> a hrefhttps://www.instagram.com target_blank relnoopener> img srchttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/db/2289/21298/icon/icon-instagram.svg altVisit us on Instagram /> span>Instagram/span> /a> /div> /div> /div> /div> /div> /div>/section> /main> /div> div classmodule-quick-links rolenavigation aria-labelHelpful Investor Relations pages> div classcontainer> ul> li> a href/news-events/email-alerts>span classmaterial-icons aria-hiddentrue>email/span>Email Alerts/a> /li> li> a classcompany-profile href/company-information>span classmaterial-icons aria-hiddentrue>location_city/span>Company Profile/a> /li> li> a href/company-information/contacts classcontacts>span classmaterial-icons aria-hiddentrue>contact_page/span>Contacts/a> /li> li> a hrefhttps://ir.fibrobiologics.com/news-events/press-releases/rss classrss target_blank relnoopener>span classmaterial-icons aria-hiddentrue>rss_feed/span>RSS News Feed/a> /li> li> a href/sitemap classsitemap>span classmaterial-icons aria-hiddentrue>account_tree/span>Sitemap/a> /li> /ul> /div>/div>footer idfooter classhas-qmod > div classfooter-main> div classcontainer> div classrow justify-content-between align-items-center> div classcol-lg-2> img classfooter-logo srchttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/db/2323/21401/image.svg width200 height50 altFibroBiologics, Inc.> /div> div classcol-lg-4> div classcopyright> ©time datetime2026>2026/time> a href/>FibroBiologics, Inc./a> All Rights Reserved. /div> /div> div classcol-lg-6> div classfooter-links> a href/privacy-policy>Privacy Policy/a>a href/disclaimer>Disclaimer/a>a href/sitemap>Sitemap/a>a href/accessibility-statement>Accessibility Statement/a> /div> /div> /div> /div> /div> div classqmod-attribution> div classcontainer> div classq-mod-attribution disclaimer> div classrow justify-content-center> div classcol-md-10 center> p> Market Data copyright © 2026 a hrefhttp://www.quotemedia.com target_blank relnofollow noopener>QuoteMedia/a>. Data delayed 15 minutes unless otherwise indicated (view a hrefhttp://www.quotemedia.com/legal/tos/#times target_blank relnofollow noopener >delay times/a> for all exchanges). span classqmf-rt>RT/span>Real-Time, span classqmf-non-rt>EOD/span>End of Day, span classqmf-non-rt>PD/span>Previous Day. Market Data powered by a hrefhttp://www.quotemedia.com target_blank relnofollow noopener >QuoteMedia/a>. a hrefhttp://www.quotemedia.com/legal/tos/ target_blank relnofollow noopener >Terms of Use/a>. /p> /div> /div> /div> /div>/div>/footer>script idcompanyVars typeapplication/json>{ asset_url: https:\/\/d1io3yog0oux5.cloudfront.net\/_c6c579a40f7c28ecf7724fd2a536e0eb\/fibrobiologics, website_base_url: https:\/\/ir.fibrobiologics.com, ir_base_url: , hCaptchaSiteKey: 778a5748-d323-4b73-a06c-9625642de8bc, isQmod: true}/script>script srchttps://d1io3yog0oux5.cloudfront.net/_c6c579a40f7c28ecf7724fd2a536e0eb/fibrobiologics/files/theme/js/_js/all.js>/script> script idqmod srchttps://qmod.quotemedia.com/js/qmodLoader.js data-qmod-wmid93303 data-qmod-envapp data-qmod-versionv1.48.0 data-qmod-storagesession defer > /script> /div>!-- //general-wrapper -->/body>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]